School News

A Loma Linda University School of Pharmacy instructor is calling for the national “Test to Treat” initiative to include pharmacists as designated providers who can both diagnose and treat COVID-19 patients in one location under Emergency Use Authorization — a move, she says, would help mitigate minority barriers to care. Assistant Professor Jacinda Abdul-Mutakabbir, PharmD, MPH, published her appeal today as a commentary in The Lancet Regional Health – Americas, co-authored by other supportive pharmacists and physicians across the nation who first saw her comments in a social media post.

After two phases of the American Society of Health-System Pharmacists (ASHP) match process, which matches pharmacy students and pharmacy residency programs across the country, the School of Pharmacy at Loma Linda University is celebrating its highest match rate since 2018. Seventy-one percent of its students and alumni seeking residency matched with health-care systems nationwide.   “Matching” is no easy accomplishment. Unlike graduates from schools of medicine, not all graduates from PharmD programs pursue additional years of training.

Loma Linda University School of Pharmacy dean and faculty are recipients of the American Pharmacists Association Immunization Champion Awards for their extraordinary contributions toward improved COVID-19 and other vaccination rates within the local community. Michael Hogue, PharmD, FAPhA, FNAP, dean of LLU School of Pharmacy, received APhA’s Immunization Champion–Lifetime Achievement Award. Jacinda Abdul-Mutakabbir, PharmD, MPH, assistant professor at LLU School of Pharmacy, received an Immunization Champion Individual Practitioner Award – Honorable Mention. The American Pharm

Start 2022 off on the right foot with LLUSP's Move-a-Thon! This event is our second annual fundraiser, organized by our Student Ambassadors, for the LLUSP Student Emergency Relief Fund. It's a fantastic way to exercise, bond with friends and take care of pharmacy students in dire financial need! Or, if you don’t want to participate, consider making a donation to LLUSP's Student Emergency Relief Fund.  Last year, we called it a Walk-a-Thon, but to allow for more kinds of exercise and abilities, we've expanded it to a Move-a-Thon.

Jacinda C. Abdul-Mutakabbir, PharmD, AAHIVP, was honored as one of the 50 most influential leaders in pharmacy by the Pharmacy Podcast Network (PPN) on November 16. The PPN created the award to honor those in the pharmaceutical community who are rising stars, innovators, trailblazers, visionaries, and leaders in the field.

Out of 13 pharmacy schools in the State of California, LLUSP's Class of 2021 ranked second on the NAPLEX - North American Pharmacist Licensure Examination and fourth on the CPJE - California Practice Standards and Jurisprudence Examination*. "Amazing students plus talented faculty, and an effective program all lead to successful outcomes,"  said Michael Hogue, PharmD, FAPhA, FNAP, dean of LLU School of Pharmacy. "Congratulations to everyone!" *Based on preliminary results

Two Doctors Discuss The Effectiveness Of At-Home COVID-19 Tests Watch professor Alireza FakhriRavari, PharmD, as he discusses the impact of at-home tests after President Joe Biden announces plans to make health insurers cover them, on CBS News Channel 2.

Loma Linda University School of Pharmacy is pleased to announce the elected Class Officers for classes 2025-2022.

LLUSP students classes 2022-2025 share what they are thankful for this year. PY1 and PY2 Students: Nicole Beisigel- (PY2) Thankful for family, thanksgiving break, and rest. Lynnette Valencia- (PY2) I’m thankful for cultivating lifelong friendships and being given the ultimate opportunity to help others through their medications. Vivian Bui- (PY1) I am thankful for a supportive family and friends and all the people in my life. Richmond Custodio- (PY2) I'm thankful for all of God's blessings that he has placed into my life.

Loma Linda University School of Pharmacy (LLUSP) announced that it is joining the RAPID Alliance Medications 360 Study, with a goal of transforming how medications and vaccines are delivered in the US from 2022 – 2031.